{"DataElement":{"publicId":"58236","version":"3","preferredName":"Leukemia French-American-British Classification Category","preferredDefinition":"a description for a grouping of hematologic malignancy (e.g., leukemia) based on criteria for morphologic and cytochemical appearance describe by French-American-British system.","longName":"LEUK_FAB_CLASS_CAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2009555","version":"3","preferredName":"Leukemia French-American-British Classification","preferredDefinition":"related to the grouping of hematologic malignancy (e.g., leukemia) based on criteria for morphologic and cytochemical appearance describe by the French-American-British international system.","longName":"LEUK_FAB_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2456829","version":"1","preferredName":"Leukemia","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. -- 2004","longName":"C3161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E070B71-9210-1732-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-13","modifiedBy":"ONEDATA","dateModified":"2006-03-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2500487","version":"1","preferredName":"French American British Classification","preferredDefinition":"A person from France or of that ancestry.:heading term for all peoples of the Americas (South, Central, and North), or western hemisphere; postcoordinate with a specific country (e.g., UNITED STATES) if necessary.:No Value Exists:Classification; the grouping of things into classes or categories.","longName":"2500487v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"French","conceptCode":"C43854","definition":"Denotes the inhabitants of France, a person from there, or their descendants elsewhere.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American","conceptCode":"C0596070","definition":"heading term for all peoples of the Americas (South, Central, and North), or western hemisphere; postcoordinate with a specific country (e.g., UNITED STATES) if necessary.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"2"},{"longName":"British","conceptCode":"C0596227","definition":"No Value Exists","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19A961EF-5C72-4E08-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-28","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19A873BD-A52E-30F4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-28","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015289","version":"3","preferredName":"Leukemia French-American-British Classification Category","preferredDefinition":"a description for a grouping of hematologic malignancy (e.g., leukemia) based on criteria for morphologic and cytochemical appearance describe by French-American-British system.","longName":"LEUK_FAB_CLASS_CAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F16-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"ALL, not otherwise specified (NOS)","valueDescription":"DISEASE CLASSIFIED AS ALL, NOT OTHERWISE SPECIFIED (NOS);","ValueMeaning":{"publicId":"2558641","version":"1","preferredName":"DISEASE CLASSIFIED AS ALL, NOT OTHERWISE SPECIFIED (NOS);","longName":"2558641","preferredDefinition":"DISEASE CLASSIFIED AS ALL, NOT OTHERWISE SPECIFIED (NOS);","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B21E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F20-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"PWEST","dateModified":"2006-08-18","deletedIndicator":"No"},{"value":"AML, not otherwise specified (NOS)","valueDescription":"DISEASE CLASSIFIED AS AML, NOT OTHERWISE SPECIFIED (NOS)","ValueMeaning":{"publicId":"2558642","version":"1","preferredName":"DISEASE CLASSIFIED AS AML, NOT OTHERWISE SPECIFIED (NOS)","longName":"2558642","preferredDefinition":"DISEASE CLASSIFIED AS AML, NOT OTHERWISE SPECIFIED (NOS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B21F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F2B-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute erythroblastic leukemia (FAB M6)","valueDescription":"DISEASE CLASSIFIED AS ACUTE ERYTHROBLASTIC LEUKEMIA (FAB M6)","ValueMeaning":{"publicId":"2558629","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE ERYTHROBLASTIC LEUKEMIA (FAB M6)","longName":"2558629","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE ERYTHROBLASTIC LEUKEMIA (FAB M6)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B212-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F36-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute lymphoblastic leukemia (FAB L2)","valueDescription":"DISEASE CLASSIFIED AS ACUTE LYMPHOBLASTIC LEUKEMIA (FAB L2)","ValueMeaning":{"publicId":"2558630","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE LYMPHOBLASTIC LEUKEMIA (FAB L2)","longName":"2558630","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE LYMPHOBLASTIC LEUKEMIA (FAB L2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B213-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F41-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute lymphoblastic leukemia (FAB L3)","valueDescription":"DISEASE CLASSIFIED AS ACUTE LYMPHOBLASTIC LEUKEMIA (FAB L3)","ValueMeaning":{"publicId":"2558631","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE LYMPHOBLASTIC LEUKEMIA (FAB L3)","longName":"2558631","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE LYMPHOBLASTIC LEUKEMIA (FAB L3)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B214-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F4C-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute lympoblastic leukemia (FAB L1)","valueDescription":"DISEASE CLASSIFIED AS ACUTE LYMPOBLASTIC LEUKEMIA (FAB L1)","ValueMeaning":{"publicId":"2558632","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE LYMPOBLASTIC LEUKEMIA (FAB L1)","longName":"2558632","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE LYMPOBLASTIC LEUKEMIA (FAB L1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B215-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F57-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute megakaryoblastic leukemia (FAB M7)","valueDescription":"DISEASE CLASSIFIED AS ACUTE MEGAKARYOBLASTIC LEUKEMIA (FAB M7)","ValueMeaning":{"publicId":"2558633","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE MEGAKARYOBLASTIC LEUKEMIA (FAB M7)","longName":"2558633","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE MEGAKARYOBLASTIC LEUKEMIA (FAB M7)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B216-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F62-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute monocytic leukemia (FAB M5)","valueDescription":"DISEASE CLASSIFIED AS ACUTE MONOCYTIC LEUKEMIA (FAB M5)","ValueMeaning":{"publicId":"2558634","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE MONOCYTIC LEUKEMIA (FAB M5)","longName":"2558634","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE MONOCYTIC LEUKEMIA (FAB M5)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B217-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F6D-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute myeloid leukemia w/ maturation (FAB M2)","valueDescription":"DISEASE CLASSIFIED AS ACUTE MYELOID LEUKEMIA W/ MATURATION (FAB M2)","ValueMeaning":{"publicId":"2558635","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE MYELOID LEUKEMIA W/ MATURATION (FAB M2)","longName":"2558635","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE MYELOID LEUKEMIA W/ MATURATION (FAB M2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B218-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F78-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute myeloid leukemia w/o maturation (FAB M1)","valueDescription":"DISEASE CLASSIFIED AS ACUTE MYELOID LEUKEMIA W/O MATURATION (FAB M1)","ValueMeaning":{"publicId":"2558636","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE MYELOID LEUKEMIA W/O MATURATION (FAB M1)","longName":"2558636","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE MYELOID LEUKEMIA W/O MATURATION (FAB M1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B219-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F83-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute myelomonocytic leukemia (FAB M4)","valueDescription":"DISEASE CLASSIFIED AS ACUTE MYELOMONOCYTIC LEUKEMIA (FAB M4)","ValueMeaning":{"publicId":"2558637","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE MYELOMONOCYTIC LEUKEMIA (FAB M4)","longName":"2558637","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE MYELOMONOCYTIC LEUKEMIA (FAB M4)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B21A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F8E-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute promyelocytic leukemia (FAB M3)","valueDescription":"DISEASE CLASSIFIED AS ACUTE PROMYELOCYTIC LEUKEMIA (FAB M3)","ValueMeaning":{"publicId":"2558638","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE PROMYELOCYTIC LEUKEMIA (FAB M3)","longName":"2558638","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE PROMYELOCYTIC LEUKEMIA (FAB M3)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B21B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0F99-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute promyelocytic leukemia-microgranular (FAB M3V)","valueDescription":"DISEASE CLASSIFIED AS ACUTE PROMYELOCYTIC LEUKEMIA-MICROGRANULAR (FAB M3V)","ValueMeaning":{"publicId":"2558639","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE PROMYELOCYTIC LEUKEMIA-MICROGRANULAR (FAB M3V)","longName":"2558639","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE PROMYELOCYTIC LEUKEMIA-MICROGRANULAR (FAB M3V)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B21C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0FA4-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Acute undifferentiated leukemia (AUL)","valueDescription":"DISEASE CLASSIFIED AS ACUTE UNDIFFERENTIATED LEUKEMIA (AUL)","ValueMeaning":{"publicId":"2558640","version":"1","preferredName":"DISEASE CLASSIFIED AS ACUTE UNDIFFERENTIATED LEUKEMIA (AUL)","longName":"2558640","preferredDefinition":"DISEASE CLASSIFIED AS ACUTE UNDIFFERENTIATED LEUKEMIA (AUL)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B21D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0FAF-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"CML, not otherwise specified (NOS)","valueDescription":"DISEASE CLASSIFIED AS CML, NOT OTHERWISE SPECIFIED (NOS);","ValueMeaning":{"publicId":"2558648","version":"1","preferredName":"DISEASE CLASSIFIED AS CML, NOT OTHERWISE SPECIFIED (NOS);","longName":"2558648","preferredDefinition":"DISEASE CLASSIFIED AS CML, NOT OTHERWISE SPECIFIED (NOS);","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B225-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0FBA-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"PWEST","dateModified":"2006-08-18","deletedIndicator":"No"},{"value":"Chronic lymphocytic leukemia (CLL)","valueDescription":"DISEASE CLASSIFIED AS CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)","ValueMeaning":{"publicId":"2558643","version":"1","preferredName":"DISEASE CLASSIFIED AS CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)","longName":"2558643","preferredDefinition":"DISEASE CLASSIFIED AS CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B220-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0FC5-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Chronic myelogenous leukemia (CML), accelerating phase, lymphoid","valueDescription":"CHRONIC MYELOGENOUS LEUKEMIA (CML), ACCELERATING PHASE, LYMPHOID","ValueMeaning":{"publicId":"2558496","version":"1","preferredName":"CHRONIC MYELOGENOUS LEUKEMIA (CML), ACCELERATING PHASE, LYMPHOID","longName":"2558496","preferredDefinition":"CHRONIC MYELOGENOUS LEUKEMIA (CML), ACCELERATING PHASE, LYMPHOID","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B18D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0FD0-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Chronic myelogenous leukemia (CML), accelerating phase, myeloid","valueDescription":"CHRONIC MYELOGENOUS LEUKEMIA (CML), ACCELERATING PHASE, MYELOID","ValueMeaning":{"publicId":"2558497","version":"1","preferredName":"CHRONIC MYELOGENOUS LEUKEMIA (CML), ACCELERATING PHASE, MYELOID","longName":"2558497","preferredDefinition":"CHRONIC MYELOGENOUS LEUKEMIA (CML), ACCELERATING PHASE, MYELOID","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B18E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0FDB-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Chronic myelogenous leukemia (CML), accelerating phase","valueDescription":"DISEASE CLASSIFIED AS CHRONIC MYELOGENOUS LEUKEMIA (CML), ACCELERATING PHASE;","ValueMeaning":{"publicId":"2558644","version":"1","preferredName":"DISEASE CLASSIFIED AS CHRONIC MYELOGENOUS LEUKEMIA (CML), ACCELERATING PHASE;","longName":"2558644","preferredDefinition":"DISEASE CLASSIFIED AS CHRONIC MYELOGENOUS LEUKEMIA (CML), ACCELERATING PHASE;","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B221-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0FE6-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"PWEST","dateModified":"2006-08-18","deletedIndicator":"No"},{"value":"Chronic myelogenous leukemia (CML), chronic phase","valueDescription":"DISEASE CLASSIFIED AS CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE","ValueMeaning":{"publicId":"2558645","version":"1","preferredName":"DISEASE CLASSIFIED AS CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE","longName":"2558645","preferredDefinition":"DISEASE CLASSIFIED AS CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B222-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0FF1-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Chronic myelogenous leukemia (CML), chronic phase, lymphoid","valueDescription":"CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE, LYMPHOID","ValueMeaning":{"publicId":"2558498","version":"1","preferredName":"CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE, LYMPHOID","longName":"2558498","preferredDefinition":"CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE, LYMPHOID","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B18F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-0FFC-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Chronic myelogenous leukemia (CML), chronic phase, myeloid","valueDescription":"CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE, MYELOID","ValueMeaning":{"publicId":"2558499","version":"1","preferredName":"CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE, MYELOID","longName":"2558499","preferredDefinition":"CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE, MYELOID","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B190-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-1007-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Chronic myelogenous leukemia, (CML), blast crisis","valueDescription":"DISEASE CLASSIFIED AS CHRONIC MYELOGENOUS LEUKEMIA, (CML), BLAST CRISIS","ValueMeaning":{"publicId":"2558646","version":"1","preferredName":"DISEASE CLASSIFIED AS CHRONIC MYELOGENOUS LEUKEMIA, (CML), BLAST CRISIS","longName":"2558646","preferredDefinition":"DISEASE CLASSIFIED AS CHRONIC MYELOGENOUS LEUKEMIA, (CML), BLAST CRISIS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B223-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-1012-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Chronic myelogenous leukemia, (CML), blast crisis, lymphoid","valueDescription":"CHRONIC MYELOGENOUS LEUKEMIA, (CML), BLAST CRISIS, LYMPHOID","ValueMeaning":{"publicId":"2558500","version":"1","preferredName":"CHRONIC MYELOGENOUS LEUKEMIA, (CML), BLAST CRISIS, LYMPHOID","longName":"2558500","preferredDefinition":"CHRONIC MYELOGENOUS LEUKEMIA, (CML), BLAST CRISIS, LYMPHOID","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B191-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-101D-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Chronic myelogenous leukemia, (CML), blast crisis, myeloid","valueDescription":"CHRONIC MYELOGENOUS LEUKEMIA, (CML), BLAST CRISIS, MYELOID","ValueMeaning":{"publicId":"2558501","version":"1","preferredName":"CHRONIC MYELOGENOUS LEUKEMIA, (CML), BLAST CRISIS, MYELOID","longName":"2558501","preferredDefinition":"CHRONIC MYELOGENOUS LEUKEMIA, (CML), BLAST CRISIS, MYELOID","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B192-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-1028-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Chronic myelomonocytic leukemia (CMML)","valueDescription":"DISEASE CLASSIFIED AS CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)","ValueMeaning":{"publicId":"2558647","version":"1","preferredName":"DISEASE CLASSIFIED AS CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)","longName":"2558647","preferredDefinition":"DISEASE CLASSIFIED AS CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B224-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-1033-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Hairy cell leukemia","valueDescription":"DISEASE CLASSIFIED AS HAIRY CELL LEUKEMIA","ValueMeaning":{"publicId":"2558649","version":"1","preferredName":"DISEASE CLASSIFIED AS HAIRY CELL LEUKEMIA","longName":"2558649","preferredDefinition":"DISEASE CLASSIFIED AS HAIRY CELL LEUKEMIA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B226-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-103E-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Mixed lineage acute leukemia","valueDescription":"DISEASE IS A MIXED LINEAGE ACUTE LEUKEMIA","ValueMeaning":{"publicId":"2558658","version":"1","preferredName":"DISEASE IS A MIXED LINEAGE ACUTE LEUKEMIA","longName":"2558658","preferredDefinition":"DISEASE IS A MIXED LINEAGE ACUTE LEUKEMIA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B22F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-1049-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Myelodysplastic syndrome (MDS) NOS","valueDescription":"DISEASE CLASSIFIED AS MYELODYSPLASTIC SYNDROME (MDS) NOS","ValueMeaning":{"publicId":"2558650","version":"1","preferredName":"DISEASE CLASSIFIED AS MYELODYSPLASTIC SYNDROME (MDS) NOS","longName":"2558650","preferredDefinition":"DISEASE CLASSIFIED AS MYELODYSPLASTIC SYNDROME (MDS) NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B227-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-1054-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Myeloproliferative syndrome NOS","valueDescription":"DISEASE CLASSIFIED AS MYELOPROLIFERATIVE SYNDROME NOS;","ValueMeaning":{"publicId":"2558651","version":"1","preferredName":"DISEASE CLASSIFIED AS MYELOPROLIFERATIVE SYNDROME NOS;","longName":"2558651","preferredDefinition":"DISEASE CLASSIFIED AS MYELOPROLIFERATIVE SYNDROME NOS;","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B228-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-105F-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"PWEST","dateModified":"2006-08-16","deletedIndicator":"No"},{"value":"Other specify","valueDescription":"OTHER SPECIFY","ValueMeaning":{"publicId":"2559668","version":"1","preferredName":"OTHER SPECIFY","longName":"2559668","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B621-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2018-05-11","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-106A-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"PWEST","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Refractory anemia (RA)","valueDescription":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA (RA)","ValueMeaning":{"publicId":"2558652","version":"1","preferredName":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA (RA)","longName":"2558652","preferredDefinition":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA (RA)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B229-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-1075-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Refractory anemia w/ excess blasts in transformation (RAEB-t)","valueDescription":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA W/ EXCESS BLASTS IN TRANSFORMATION (RAEB-T)","ValueMeaning":{"publicId":"2558653","version":"1","preferredName":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA W/ EXCESS BLASTS IN TRANSFORMATION (RAEB-T)","longName":"2558653","preferredDefinition":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA W/ EXCESS BLASTS IN TRANSFORMATION (RAEB-T)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B22A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-1080-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Refractory anemia w/ ring sideroblasts (RARS)","valueDescription":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA W/ RING SIDEROBLASTS (RARS)","ValueMeaning":{"publicId":"2558654","version":"1","preferredName":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA W/ RING SIDEROBLASTS (RARS)","longName":"2558654","preferredDefinition":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA W/ RING SIDEROBLASTS (RARS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B22B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-108B-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Refractory anemia w/excess blasts (RAEB)","valueDescription":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA W/EXCESS BLASTS (RAEB)","ValueMeaning":{"publicId":"2558655","version":"1","preferredName":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA W/EXCESS BLASTS (RAEB)","longName":"2558655","preferredDefinition":"DISEASE CLASSIFIED AS REFRACTORY ANEMIA W/EXCESS BLASTS (RAEB)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B22C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-1096-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Unclassifiable acute leukemia","valueDescription":"DISEASE IS AN UNCLASSIFIABLE ACUTE LEUKEMIA","ValueMeaning":{"publicId":"2558659","version":"1","preferredName":"DISEASE IS AN UNCLASSIFIABLE ACUTE LEUKEMIA","longName":"2558659","preferredDefinition":"DISEASE IS AN UNCLASSIFIABLE ACUTE LEUKEMIA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B230-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-10A1-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"},{"value":"Undifferentiated acute myeloid leukemia (FAB M0)","valueDescription":"DISEASE CLASSIFIED AS UNDIFFERENTIATED ACUTE MYELOID LEUKEMIA (FAB M0)","ValueMeaning":{"publicId":"2558657","version":"1","preferredName":"DISEASE CLASSIFIED AS UNDIFFERENTIATED ACUTE MYELOID LEUKEMIA (FAB M0)","longName":"2558657","preferredDefinition":"DISEASE CLASSIFIED AS UNDIFFERENTIATED ACUTE MYELOID LEUKEMIA (FAB M0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B22E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19A7F6D4-10AC-3B06-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"ONEDATA","dateModified":"2006-07-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184279","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"Category","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1A66-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"19A7F6D4-0F01-3B06-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-28","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"SOKKERL","dateModified":"2018-05-11","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000449","version":"1","longName":"ALL Prev Untreated","context":"CTEP"},{"publicId":"10000362","version":"1","longName":"AML Prev Untreated","context":"CTEP"},{"publicId":"2811786","version":"1","longName":"APL Prev Untreated","context":"CTEP"},{"publicId":"2811797","version":"1","longName":"CML Prev Untreated","context":"CTEP"},{"publicId":"2811806","version":"1","longName":"MDS Prev Untreated","context":"CTEP"},{"publicId":"2811921","version":"1","longName":"ALL Relapse/Refract","context":"CTEP"},{"publicId":"2811922","version":"1","longName":"AML Relapse/Refract","context":"CTEP"},{"publicId":"2811923","version":"1","longName":"APL Relapse/Refract","context":"CTEP"},{"publicId":"2811925","version":"1","longName":"CML Relapse/Refract","context":"CTEP"},{"publicId":"2811928","version":"1","longName":"MDS Relapse/Refract","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Leukemia Classification","type":"Preferred Question Text","description":"Leukemia Classification","url":null,"context":"CTEP"},{"name":"COMMENT_306","type":"COMMENT","description":"Make this a pick list that limits the list to the specific type of leukemia being studied.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Leukemia/MDS Classification","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Primary morphology of the patient's AML","url":null,"context":"COG"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19A9160B-A1A3-4328-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-28","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-28","modifiedBy":"LEEW","dateModified":"2015-06-01","changeDescription":"updated for ISO Compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}